Early ID study: Difference between revisions

From CCMDB Wiki
Jump to navigation Jump to search
Line 31: Line 31:
* Preliminary End Date: 1 month to 3 months after start date
* Preliminary End Date: 1 month to 3 months after start date


== Lead ==
== Project team ==
* contact for project at the data collection end:  
* Primary contact for Data Collection: [[Con Marks]] ''R.N.''
**  [[Con Marks]]
*Project lead and main contact for project
* lead contact for this project at the requestor's end:
** '''Dr. John Embil''' ''Director, Infection Diseases Program''
** Dr. John Embil Director, Infection Diseases Program.
** '''Terry Wuerz''',  ''resident physician''
** Terry Wuerz - resident physician


== Consistency Checks ==
== Consistency Checks ==

Revision as of 23:01, 2011 January 20

Purpose

To find out if early notification and involvement by Infectious Disease of positive blood cultures will have an impact on improving patient outcome.

Collection Instructions in TMP file

The lab will send a list of all patients with positive cultures to Con (GF216). For all patients on this list who are on the study wards (A4 and D4) or the control group wards (H4, H4H, H7 contingency beds), enter:

  • "Sample Drawn": date and time sample was drawn
  • "Positive Culture": date and time of positive culture
  • "ID Consult": date and time Infectious Disease Department consult response
    • if no response or patient leaves, deceased or AMA then check box "no response"
  • "Order": date and time order written to change to appropriate antibiotic, if change is needed
    • if no change or patient leaves, deceased or AMA then check box "not avail."

Template:Discussion do they want to know the actual antibiotics or will they get that from elsewhere? Ttenbergen 14:01, 20 January 2011 (CST)

      • Yes they would like the name/s of antibiotic/s used.--CMarks 14:12, 20 January 2011 (CST)
  • "Orig Antibiotic": date and time of original antibiotic prescription, actual ab neeeded?
      • Yes please include name/s of original antibiotic/s.--CMarks 14:12, 20 January 2011 (CST)
    • if patient was not on an antibiotic before, then check box "no orig ab"
  • "Antibiotic": date and time new antibiotic is given, actual ab neeeded?
    • yes.--CMarks 14:12, 20 January 2011 (CST)
    • if no new antibiotic is given or patient leaves, deceased or AMA then check box "no new AB"
    • enter another "Antibiotic" line if switching to another antibiotic later

Special Cases

Suggested to Con to use similar to QA Septic Ttenbergen 13:34, 24 December 2010 (CST) Template:Discussion

Study Run Times

  • Approved by Dr Roberts: January 2010
    • Tentative start date "January 31, 2011" --CMarks 16:05, 17 January 2011 (CST)
  • Review Date: 30 days after start date. Week of March 7.11.
  • Preliminary End Date: 1 month to 3 months after start date

Project team

  • Primary contact for Data Collection: Con Marks R.N.
  • Project lead and main contact for project
    • Dr. John Embil Director, Infection Diseases Program
    • Terry Wuerz, resident physician

Consistency Checks

Tmp Checker will check for the following:

  • dates will need to be consistent with admit/discharge; waiting to hear back what rules will be for pts who leave.Ttenbergen 13:24, 24 December 2010 (CST) Template:Discussion
  • If "Positive Culture" entry is present for a patient, then there will have to be either a date or a checkbox for the other entries.
  • If patient discharged and blood culture result not back before this, follow the 5 day rule to see if culture is positive before sending as a completed data file.--CMarks 14:17, 20 January 2011 (CST)

Sending to TmpV2.mdb

Will data be sent for every patient at every send.

  • Data will be sent only for the completed patient data files as is normally done on Wednesdays.--CMarks 14:22, 20 January 2011 (CST)

Statistician

The following data needs to be reported back to Dr. Embil, pending review at the review date above:

  • Early ID Study data from TMPV2,Initials, ward location chart number, LOS, admit date, discharge date,and complications & comorbid conditions.
  • In 1 month - the above raw data to be sent to Dr. Embil (in Excel would be fine). Julie will pull needed elements from ccmdb, database and TMPV2 and sent to Dr. Embil. This would be the end of the first week of March. The information will analyzed by Dr. Embil and team.
  • Dr. Embil may asks Julie later in the project if it is continued do some minor analysis.